Francisella tularensis is a highly infectious Gram-negative bacterium, living mostly on the Northern hemisphere, and considered as a biothreat agent. People can be infected from its reservoirs in rodents and lagomorphs not only by direct contact with them, their excrements, or urine, but also through soil, water, and air, or even by arthropod bites. The resulting illness, tularemia, can develop in various forms, depending both on the route of entrance (ulceroglandular, oculoglandular, oropharyngeal, respiratory or enteral tularemia), and on the subspecies of the bacterium. Francisella tularensis tularensis (type A), typical for North America, is extremely virulent (the infective dose in human is 25 bacteria taken by aerosol or 10 bacteria taken subcutaneously) and can cause rhabdomyolysis and septic shock. After the advent of effective antibiotics, the mortality declines from 5-10% to 1-2%. Francisella tularensis holarctica (type B) is spread more widely over the Northern hemisphere, but it is less virulent and virtually nonlethal even without antibiotic treatment, although high fever and other symptoms occur even in this case. We have added to our portfolio three rabbit polyclonal antibodies that can be used to distinguish between F. tularensis tularensis and F. tularensis holarctica subspecies by Western blotting and ELISA:
PAb (180): Anti-PilT (F. tularensis ssp. tularensis) Purified 11-180-C100
PAb (181): Anti-FTT0571 (F. tularensis ssp. tularensis) Purified 11-181-C100
PAb (196): Anti-FTL0187 (F. tularensis ssp. holarctica) Purified 11-196-C100
Fig. 1: Western blotting analysis of polyclonal anti-Francisella tularensis subsp. tularensis antigen FTT0088 (11-180-C100). FSC200-CL: 10 μg of F. tularensis ssp. holarctica FSC200 cell lysate SCHUS4-CL: 10 μg of F. tularensis ssp. tularensis SCHU S4 cell lysate FSC200-MF: 10 μg of F. tularensis ssp. holarctica FSC200 membrane fraction SCHUS4-CL: 10 μg of F. tularensis ssp. tularensis SCHU S4 membrane fraction K1: 50 ng of FTT0088 recombinant protein K2: 125 ng of FTT0088 recombinant protein Fig. 2: Western blotting analysis of polyclonal anti-Francisella tularensis subsp. holarctica antigen FTL0187 (11-196-C100). FSC200-CL: 10 μg of F. tularensis ssp. holarctica FSC200 cell lysate SCHUS4-CL: 10 μg of F. tularensis ssp. tularensis SCHU S4 cell lysate FSC200-MF: 10 μg of F. tularensis ssp. holarctica FSC200 membrane fraction SCHUS4-CL: 10 μg of F. tularensis ssp. tularensis SCHU S4 membrane fraction K1: 50 ng of FTL0187 recombinant protein K2: 125 ng of FTL0187 recombinant protein Further reading: Tärnvik A, Berglund L: Tularemia. Eur Respir J. 2003;21:361-373. Telford SR, Goethert HK: Ecology of Francisella tularensis. Annu Rev Entomol. 2020;65:351-372. Carruthers J, Lythe G, López-García M, Gillard J, Laws TR, Lukaszewski R, Molina-París C: Stochastic dynamics of Francisella tularensis infection and replication. PLoS Comput Biol. 2020;16(6):e1007752.
Contact: info@exbio.cz
Anti-human CD38 clones HB7 and HIT2 were compared regarding their reactivity with particular blood cell populations.
Here we present two basic systems of biotin detection, namely anti-biotin monoclonal antibody and streptavidin conjugates.
Anti-human CD25 clones MEM-181, B1.49.9, 2A3, BC96, CD25-4E3, and CD25-3G10 were compared regarding their reactivity with particular blood cell populations.